Treatment of Acute Heparin-Induced Thrombocytopenia with Thrombosis (HITT) or Without Thrombosis (Isolated HIT)

This protocol covers the first-line management of acute heparin-induced thrombocytopenia, whether presenting with associated thrombosis (HITT) or as isolated thrombocytopenia without thrombosis.

Clinical Scenario

This approach applies to patients with acute heparin-induced thrombocytopenia with thrombosis (HITT) or acute isolated heparin-induced thrombocytopenia without thrombosis. Both presentations are addressed by this evidence-based first-line protocol.

First-Line Approach

Management requires immediate discontinuation of heparin and initiation of a non-heparin anticoagulant at therapeutic intensity — agent choice and course vary by presentation.

Full agent selection, sequencing, and duration criteria are detailed in the structured protocol.

Treatment Goal

Platelet count recovery, typically to a platelet count of ≥150 × 10⁹/L.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1182/bloodadvances.2018024489

In patients with HITT or acute HIT without thrombosis (isolated HIT), the ASH guideline panel recommends discontinuation of heparin and initiation of a non-heparin anticoagulant (strong recommendation, moderate certainty in the evidence about effects).

View source ↗